SynthesisCNS drugs2021

Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists.

David M Kern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.